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Abstract: 
 
Many regulated epigenetic elements and base lesions found in genomic DNA can both directly 
impact gene expression and play a role in disease processes. However, due to their noncanonical 
nature, they are challenging to assess with conventional technologies. Here, we present a new 
approach for the targeted detection of diverse modified bases in DNA. We first use enzymatic 
components of the DNA base excision repair pathway to install an individual affinity label at 
each location of a selected modified base with high yield. We then probe the resulting material 
with a solid-state nanopore assay capable of discriminating labeled DNA from unlabeled DNA. 
The technique features exceptional modularity via selection of targeting enzymes, which we 
establish through the detection of four DNA base elements: uracil, 8-oxoguanine, T:G mismatch, 
and the methyladenine analog 1,N6-ethenoadenine. Our results demonstrate the potential for a 
quantitative nanopore assessment of a broad range of base modifications. 
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Article: 
 
A variety of noncanonical bases are prevalent in genomic DNA and play crucial roles in cell 
functions that include gene expression and suppression,(1) transposon expression,(2, 3) stem cell 
differentiation,(4) and chromosomal inactivation.(5) For example, the abundance and position of 
epigenetic modifications are tightly regulated and errors in this regulation have been linked to a 
wide range of diseases(6) including cancer. In addition, DNA base damage elements generated 
both endogenously and exogenously are a major source of point mutations if not correctly 
repaired by cellular processes. The locations of these elements can be random or could be linked 
to sequence accessibility in chromatin structures. While the impact of modified DNA bases is 
clear, their detection can be challenging. For example, direct sequencing approaches typically 
lack the ability to identify noncanonical bases that may be present in DNA,(7) with some 
extension to the epigenetic modification methylcytosine, specifically.(8) Conventional 
technologies like mass spectrometry and high-performance liquid chromatography are 
burdensome, expensive, and destructive to the DNA and in some cases can induce additional 
lesions,(9) leading to the misrepresentation of density. In addition, immunological methods like 
the enzyme-linked immunosorbent assay (ELISA) rely on antibodies that can suffer from cross-
reactivity.(10) One approach that addresses some of these concerns has been pioneered recently by 
Song et al.(11) in which a single, high-affinity tag was attached enzymatically to 5-
hydroxymethylcytosine bases, permitting downstream analysis, enrichment, or sequencing. 
While the process has been adapted to access some additional elements of the demethylation 
pathway,(12-14) only a limited suite of modifications are suitable for such tagging. As the ability to 
probe a wide variety of base modifications would be of significant value, we set out to develop a 
new, modular strategy employing solid-state (SS) nanopore technology that would be permissive 
for a host of different DNA modifications. 
 
SS nanopores(15, 16) have been widely studied as a means to assess biological molecules like 
DNA,(17, 18) RNA,(19, 20) and proteins(21-23) using the principle of resistive pulse sensing. The 
platform consists of an insulating thin-film membrane that contains a nanometer-scale pore, 
positioned in an electrolyte solution. Application of an electrical bias across the membrane 
generates an electric field through the pore, and as charged molecules are threaded 
electrophoretically one-by-one, they temporarily occlude the aperture and interrupt the measured 
ionic current. These brief electrical disruptions are designated as “events”, and their properties 
have been used to study molecular attributes,(24) probe intermolecular interactions,(25, 26) and 
determine analyte concentrations.(27, 28) Historically, a significant limitation of this measurement 
approach has been a lack of selectivity: all molecules of like-charge will translocate and 
contribute to the overall signal, thus requiring differentiation ex post facto via often subtle 
differences in event characteristics. We have developed a SS nanopore assay that enables nearly 
binary detection and quantification of DNA featuring a single biotin affinity tag.(29) Briefly, 
when target DNA fragments (below ∼250 bp) or a key chaperone protein (monovalent 
streptavidin,(30) MS) are introduced individually to an SS nanopore of appropriate diameter, their 
rapid translocations prevent events from being resolved by conventional electronics (Figure 1a, 
left and center). However, when the two molecules bind, the larger nucleoprotein complex 
interacts with the walls of the nanopore during passage, slowing its translocation to a resolvable 
speed and yielding events (Figure 1a, right). Recently, we expanded this basic approach to assess 
hydroxymethylcytosine epigenetic modifications(28) by employing an established method for 
specific biotin labeling of the base,(11) enabling direct assessment of a base modification with 
physiological relevance. However, the scope of possible targets for the labeling approach was 
limited intrinsically by enzymatic recognition. Here, we enhance our SS nanopore measurement 
scheme significantly by integrating it with an alternative, modular labeling technique that 
enables the targeted detection of diverse base modifications. 
 
 
Figure 1. (a) Depiction of the selective SS nanopore assay. Individual passage of a short DNA (left) or a chaperone 
protein (MS, center) yields no events due to the high translocation speed (red arrows); a DNA–protein complex 
(right) interacts with the pore walls (yellow arrows), resulting in slower translocation speed (green arrow) and 
resolvable events. Sample conductance traces at bottom were measured at 300 mV using 75 bp DNA (500 nM) with 
a synthetic biotin. (b) Schematic representation of the general labeling approach. (i) A duplex DNA molecule 
featuring a target base element (red). (ii) A glycosylase recognizes and excises the base element (diagram shows the 
activity of a bifunctional glycosylase that nicks the phosphate backbone 3′ to the excision). (iii) An AP endonuclease 
cuts the backbone 5′ to the excision. (iv) A gap-filling polymerase incorporates a single biotinylated nucleotide at 
the modification position. (c) SS nanopore analyses of 250 nM DNA oligonucleotides featuring either a single uracil 
(at nucleotide position 34, top) or a single oxoG (at nucleotide position 28, bottom). Data points indicate 
measurements on treated DNA with (blue) and without (black) MS. Filled circles and open diamonds are 
independent measurements on different SS nanopore devices, and all lines are exponential fits to the data. Dramatic 
increases in event rate are measured for DNA-MS when a glycosylase specific for the target base is used (blue data, 
upper left and lower right). Almost no effect is observed for mismatched glycosylase (blue data, upper right and 
lower left). Insets: denaturing gel analyses of the same DNA constructs (steps numbered as in b). Lane 1: annealed 
oligonucleotide; lane 2: following glycosylase/endonuclease treatment; lane 3: following T4(exo-) fill-in. * indicates 
DNA length plus biotin tag. Right: molecular structures of the target bases. 
 
Similar to a recent report by Riedl et al.,(31) our methodology exploits the enzymatic machinery 
of the DNA base excision repair (BER) pathway, which identifies and restores base lesions in 
vivo. In our approach (Figure 1b), a modified base element was first excised from the DNA 
using a DNA glycosylase, which removed the target base from the phosphate backbone, leaving 
an abasic (AP) site. If the glycosylase was bifunctional (i.e., had AP lyase activity), the 
phosphodiester bond was also cleaved 3′ to the modification, leaving a single strand nick. The 
ensuing steps were not affected by this activity. Next, an AP endonuclease was used to cleave the 
phosphodiester bond 5′ to the abasic site and remove the exposed 3′ phosphate, leaving a 
hydroxyl group that was amenable to the final step: treatment with a gap-filling polymerase to 
incorporate a biotin-conjugated nucleotide into the DNA structure. For this, we used a mutant 
polymerase lacking 3′–5′ exonuclease activity (T4(exo-)) and provided it with only one of the 
cognate biotin-dNTP, resulting in the insertion of a single affinity label at the precise location of 
the modified base. We have found the absence of exonuclease activity to be particularly 
important as processive cleavage of nucleotides from the modification site can result in the 
prevention or misincorporation of the biotinylated nucleotide label. We note that this 
methodology ultimately resulted in a nick 3′ to the inserted biotin-dNTP. While it should be 
possible to repair this nick through ligation, we did not include such a step because of the 
potential for reduced product yield. The presence of the nick did not negatively impact 
subsequent measurements. 
 
Crucially, this general approach could be used to target a variety of distinct modified bases 
through variation of two central components: the DNA glycosylase, selected for recognition of a 
particular lesion, and the biotin-conjugated nucleotide, selected to match the canonical identity of 
the target modified base (or in the case of a mismatch target, the appropriate nucleotide for 
Watson–Crick base-pairing with the opposite strand). As an initial demonstration of this 
modularity, we first showed selective detection of uracil and oxoguanine (oxoG) bases. Uracils 
arise in DNA upon deamination of cytosine, resulting in a mutagenic U:G mismatch, or upon 
misincorporation of dUTP, resulting in a genotoxic U:A pair.(32) Meanwhile, oxoG is the major 
oxidative base damage associated with reactive oxygen species (ROS) due to the low redox 
potential of guanine and has known mutagenic potential via transversion during DNA 
replication.(33) For these measurements, we used synthetic 40 bp double-strand (ds-) DNA 
oligonucleotides, with one strand containing the target modified base at a known position and a 
fluorescent FAM label at the 5′ end. We utilized endonuclease IV (EndoIV) to prime the excised 
gap for T4(exo-) incorporation of a biotin-dNTP. 
 
Denaturing gel analysis (Figure 1c insets) of each sequential step for the two bases using an 
appropriate glycosylase/nucleotide combination showed the excision of the modified base and 
incorporation of the biotin-dNTP. Labeling of uracil was achieved using a combination of uracil 
DNA glycosylase (UDG) and biotin-dUTP, while oxoG labeling employed human oxoG DNA 
glycosylase (hOGG1) and biotin-dGTP. Notably, we made use of a “one-pot” treatment for each 
of these targets (see Materials and Methods) that minimized material loss and enabled high 
product yields of ∼92% and ∼83%, respectively. In addition, UDG is a monofunctional 
glycosylase, while hOGG1 is bifunctional, showing that the approach was not affected 
significantly by either absence or presence of AP lyase activity in the glycosylase. Identical 
treatments of each base modification with nontarget components showed no significant labeling, 
highlighting process selectivity that was facilitated by the low cross-recognition of each 
glycosylase (Supplementary Figures S1–2). 
 
SS nanopore analyses of the same labeling products demonstrated clear specificity in the 
resulting electrical signal as well. For the appropriate combinations of base modification and 
enzymes, we observed exponential voltage-dependent event rates (Figure 1c), characteristic of 
the assay.(28, 34) Provided with the same total DNA concentrations (250 nM), the nearly identical 
event rate trends for both cases further indicated not only the similarity of the yields for the two 
labeling protocols, but also the reproducibility of the assay. In contrast, mismatched components 
yielded negligible event rates that were indistinguishable from negative controls across the entire 
investigated range of applied voltage (Figure 1c, black). These results suggested that nonspecific 
labeling of DNA was insignificant, including at the 3′ ends of the molecule (Supplementary 
Figure S3) and confirmed intrinsic discrimination for an intended base element. 
 
While these data clearly demonstrated a flexible approach that could in principle be extended to 
a broad range of base targets,(35) glycosylases can also have additional activities that could 
interfere with the labeling procedure as described. For example, thymine DNA glycosylase 
(TDG) is a major component of the cytosine demethylation process, recognizing T:G 
mismatches(36) among other elements,(37) but it also recruits additional enzymes like histone 
acetyltransferases.(38) Because of this latter role, TDG has a high affinity for the AP site resulting 
from base excision, making it difficult to detach for subsequent labeling steps (Figure 2a). To 
address this, we sought to promote enzyme disengagement through the incorporation into the 
protocol of an additional endonuclease, AP endonuclease 1 (APE1). The extensive dsDNA 
binding surface of APE1 and the prominent kinking it induces in the DNA helix(39) have been 
suggested as means to promote displacement of glycosylases more efficiently than EndoIV.(40) 
However, the improved activity of APE1 comes at the expense of 3′–5′ exonuclease activity not 
found in the other enzyme, especially under key buffer conditions.(41) To partially mitigate this 
effect, we used the APE1 D308A mutant,(42) which features reduced 3′–5′ exonuclease activity. 
This inclusion improved yield significantly over wild type APE1 (Supplementary Figure S4), but 
the remaining nucleotide digestion activity still necessitated a supplementary purification step 
prior to polymerase gap filling to limit decomposition of the DNA. While this increased the 
number of steps and decreased overall product yield somewhat, the resulting material showed the 
successful incorporation of biotin-labeled nucleotides on gel (Figure 2b) at a high yield (∼73%), 
as well as selective detection by our SS nanopore assay (Figure 2c). Indeed, we recovered the 
same exponential trend in the measured SS nanopore event rate and the same selectivity over a 
negative control as found for uracil and oxoG. The event rate dependence was slightly higher for 
TDG labeling than for previous examples, which could be due to minor residual enzyme binding 
or small differences in pore attributes (diameter, shape, etc.). 
 
Notably, this alternative method could be used to incorporate other glycosylases with similar 
behavior as well. As an example, we utilized human alkyladenine DNA glycosylase (hAAG), 
which excises alkylated bases from DNA, but has also been observed to bind tightly to its DNA 
template.(43) The major target of hAAG is the important epigenetic element methyladenine,(44) 
but this base is known to be unstable for in vitro measurements. Consequently, we instead used 
for our demonstration a synthetic oligonucleotide featuring the methyladenine analog 1,N6-
ethenoadenine, and employed hAAG and biotin-dATP for labeling. Subsequent analyses of the 
product again indicated efficient (∼74%) labeling on gel (Figure 3a) and a selective event rate 
increase in SS nanopore measurements (Figure 3b). We noted additional spread in the data at low 
voltages (<400 mV) specific to the labeled 1,N6-ethenoadenine DNA, which we suggest may 
have been due to structural irregularities associated with the modified base itself (see 
Supplementary Figure S5). We also observed a lower maximum rate at 600 mV, which we 
attributed to the smaller length(28) of this DNA as compared to the other constructs described in 
this report. However, the selective rate difference is easily resolved, demonstrating the broad 
modularity of both the labeling scheme and the measurement approach. 
 
 
Figure 2. (a) Top: Schematic showing inaccessibility of AP site by EndoIV caused by TDG binding. Bottom: 
denaturing gel of labeling steps for a T:G mismatch oligonucleotide using EndoIV only. No significant labeling is 
observed. (b) Top: schematic showing release of TDG by APE1, leaving DNA accessible by EndoIV. Bottom: 
denaturing gel of labeling steps for a T:G mismatch oligonucleotide using both EndoIV and APE1 (D308A mutant), 
indicating recovery of high yield labeling. * indicates DNA length plus biotin tag. (c) SS nanopore analysis of 250 
nM labeled construct from (b) both with (blue) and without (black) MS. Filled circles and open diamonds are 
independent measurements on different SS nanopore devices, and lines are exponential fits to the data. Inset: 
molecular structure of the T:G mismatch base element. 
 
 
Figure 3. (a) Denaturing gel of labeling steps for a 1,N6-ethenoadenine oligonucleotide using EndoIV and APE1 
(D308A mutant), showing high yield biotin labeling. * indicates DNA length plus biotin tag. (b) SS nanopore 
analysis of 250 nM labeled construct from (a) both with (blue) and without (black) MS. Filled circles and open 
diamonds are independent measurements on different SS nanopore devices and lines are exponential fits to the data. 
Inset: molecular structure of 1,N6-ethenoadenine. 
 
In conclusion, we have shown that a variety of single-base modifications can be assessed with a 
selective SS nanopore assay. This was achieved by incorporating an efficient and targeted 
affinity-labeling technique that exploited the physiological activities of enzymes involved in the 
BER pathway to install a single biotin tag at the precise location of a given base element. We 
first showed selective recognition of uracil and oxoG bases with the glycoslyases UDG and 
hOGG1, respectively. Next, we sought to utilize other glycosylases by integrating a mixture of 
endonucleases designed to promote enzyme release and limit DNA digestion. While the 
alternative procedure entailed some loss of material due to increased exonuclease activity, it 
enabled the use of glycosylases that are specifically challenging to incorporate in the labeling 
approach due to strong AP binding capacity. As a demonstration, we showed that this approach 
could be used for the study of T:G mismatch bases with TDG and the methyladenine analog 
1,N6-ethenoadenine with hAAG. Therefore, with the flexible protocols established here, nearly 
any glycosylase could be integrated, facilitating the labeling and analysis of a broad range of 
bases that they target, including the widely studied methylcytosine.(45) The central limiting factor 
for this capacity is in the specificities of the glycosylases themselves, since many have 
recognition for multiple elements. However, the affinity for specific targets can vary wildly, 
offering a potential pathway to high selectivity and we expect that the use of point mutations in 
the glycosylases may also be able to tailor their specificity and enable high certainty in 
recognition. 
 
These validatory measurements were performed using concentrations of 250 nM, corresponding 
to ∼65 ng of DNA per run in our current protocols. Even taking into account sample loss during 
the labeling procedure and the general low physiological abundance of modified bases, amounts 
of genomic DNA capable of supporting this assessment could in principle be obtained from 
microliter volumes of whole blood using commercial kits (e.g., QIAamp DNA Mini Blood Mini 
Kit). We also note that our approach has been verified(34) to resolve concentrations down to at 
least 10 nM without adjustment, making pertinent, clinically derived materials still more easily 
attainable. Coupled with the quantitative nature of the technique(28) and its viability among a 
background of nontarget components,(29, 34) our results establish a highly selective and 
translational SS nanopore assay. The physiologically relevant base modifications that it targets 
may have important impacts on biology and disease but are challenging to probe through 
conventional means. Furthermore, the modular labeling approach itself could also be employed 
independently in applications like affinity enrichment and genomic analyses(11-13) and is 
amenable to the integration of any label that can be incorporated by polymerase activity, 
including fluorescent tags. 
 
SS Nanopore Measurements 
 
Fabricated silicon chips (4 × 4 mm), each supporting a 10–20 μm thin film silicon nitride 
window (20 nm thickness), were obtained commercially (Norcada, Inc., Alberta, Canada). A 
single SS nanopore (diameter 7.5–9.0 nm, as determined from resistance measurement(27)) was 
produced in each membrane using a helium ion milling technique described elsewhere.(46) Prior 
to measurement, a chip was rinsed with deionized water and ethanol, dried under filtered air 
flow, and then exposed to air plasma (30 W) for 2 min on each side before being placed into a 
custom Ultem 1000 flow cell that enabled introduction of measurement buffer (1 M NaCl, 10 
mM PBS buffer) to independent reservoirs on each side of the device. Ionic current 
measurements were performed with a patch clamp amplifier (Axopatch 200B) through Ag/AgCl 
electrodes and used to verify pore diameter. After introducing biomolecules in measurement 
buffer to the cathode chamber, the current was recorded at a bandwidth of 200 kHz with a 100 
kHz four-pole Bessel filter. Analysis was performed with custom software and an additional low-
pass filter of 25 kHz. The event threshold for analysis was set at 4.5 standard deviations above 
the RMS noise level, and only events with durations between 12.5 μs and 2.5 ms were 
considered. Each rate measurement was determined by considering at least 3.5 min of 
uninterrupted trace recording, broken into segments of 3.2 s. The standard deviation between 
segments was taken as the measurement error. 
 
Gel Electrophoresis 
 
The denaturing gel was prepared by mixing thoroughly 70 mL of 23% gel matrix (22% 
acrylamide, 1% bis-acrylamide, 7 M urea in 1× tris/borate/EDTA (3:1:1) (TBE) buffer), 240 μL 
of 25% ammonium persulfate, and 42 μL of tetramethylethylenediamine. The gel mixture was 
cast and allowed to polymerize for 30 min before running samples with dye in 1× TBE (3:1:1) at 
55 W for 90 min. Yields were approximated by measuring product band intensity relative to 
intermediates in the final lane using ImageJ analysis software.(47) For electromobility shift assays 
(EMSA) gels (see Supplementary Figure S3), 3.5% agarose gels were prepared in 1× TBE buffer 
with GelRed nucleic acid stain (Phenix Research Products, Candler, NC). Gel images were 
acquired using a Gel Doc system (Bio-Rad, Hercules, CA). 
 
APE1 D308A Protein Expression 
 
APE1 D308A plasmid (provided by the Demple Lab, Stony Brook University) was transformed 
into BL21*(DE3) cells and grown in 1 L LB broth at 37 °C. After bacterial cell cultures reached 
OD600 = 0.6, expression was induced with 0.5 mM isopropyl β-d-thiogalactopyranoside (IPTG). 
The cultures were then incubated for another 90 min before being harvested by centrifugation, 
resuspended in 50 mM HEPES-KOH (pH 7.5), 100 mM KCl, 1 mM EDTA, 0.1 mM DTT, and 
10% (v/v) glycerol, and lysed by two passes through an EmulsiFlex-C5 (Avestin, Ottawa, 
Canada). The lysate was cleared by centrifugation at 20 000 g for 20 min, loaded onto a 15 mL 
SP Sepharose column (GE Healthcare, Pittsburgh, PA), and eluted with a linear gradient of 100–
750 mM KCl. Elutions were analyzed by SDS-PAGE and fractions containing the protein were 
pooled and dialyzed overnight at 4 °C against APE1 storage buffer (50 mM HEPES-KOH (pH 
7.5), 200 mM KCl, 1 mM EDTA, 0.1 mM DTT, 10% (v/v) glycerol) and concentrated using 10 
kDa MWCO centrifugal spin filter columns (EMD Millipore, Billerica, MA). The final protein 
concentration was determined with the Bio-Rad Protein Assay (Bio-Rad), and aliquots were 
stored at −20 °C prior to use. 
 
TDG Protein Expression from E. coli 
 
We followed a protocol adapted by Liu et al.(48) from earlier work(49) with minor modifications. 
An expression plasmid for human TDG based on pET28 was transformed into BL21(DE3) cells 
and grown in 1 L LB broth at 37 °C. Once the cultures reached OD600 = 0.6, they were gradually 
cooled to 16 °C, induced with 0.25 mM IPTG and grown overnight. Cells were harvested by 
centrifugation, resuspended in 20 mL of TDG lysis buffer (50 mM sodium phosphate, pH 8.0, 
300 mM NaCl, 25 mM imidazole) with protease inhibitors, and lysed by two passes through an 
EmulsiFlex-C5. The lysate was cleared by centrifugation at 20 000 g for 20 min, loaded onto a 1 
mL column of HisPur cobalt resin (Fisher Scientific) equilibrated with TDG lysis buffer, and 
bound by two applications of the lysate to the column under gravity flow. The column was 
washed with 20 mL of TDG lysis buffer and subsequently eluted in 1 mL aliquots by a linear 
gradient of 100–500 mM imidazole. Elutions were analyzed by SDS-PAGE, and fractions 
containing the protein were pooled and dialyzed overnight at 4 °C against TDG storage buffer 
(20 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 1% v/v glycerol). 
Dialyzed proteins were concentrated using 10 kDa MWCO centrifugal spin filter columns. The 
final TDG concentration was determined with the Bio-Rad Protein Assay, and aliquots were 
stored at −80 °C prior to use. 
 
Uracil Labeling 
 
A custom 40 nt oligonucleotide with a 5′ FAM (sequence: TCA CGA CTA GTG TTA ACA 
TGT GCA CCT GCA GAA UGA GAA T) was annealed to a complementary sequence by 
mixing both at an equimolar ratio, incubating in deionized water at 95 °C for 10 min, and cooling 
to room temperature over 1 h. To cap the 3′ ends of the DNA, a 100 μL aliquot was prepared 
containing 385 pmol of duplex DNA, 30 nmol of 2′,3′-dideoxyadenosine 5′-triphosphate 
(ddATP) (GE Healthcare), 500 U of terminal transferase (New England Biolabs, Ipswich, MA), 
and 25 mmol CoCl2 (New England Biolabs) and incubated in 1× terminal transferase reaction 
buffer (New England Biolabs) at 37 °C for 1.5 h. The resulting material was purified with the 
QIAquick PCR purification kit (Qiagen, Valencia, CA) to allow for buffer exchange. To excise 
uracil, a 30 μL aliquot was prepared containing 100 pmol of capped duplex DNA, 20 U of E. 
coli UDG (New England Biolabs), 40 U of EndoIV (New England Biolabs), 3 μg of bovine 
serum albumin (BSA, New England Biolabs), and incubated in 1× NEB2 buffer (New England 
Biolabs) at 37 °C for 1 h. Next, 1.5 nmol of biotinylated dUTP (PerkinElmer, Waltham, MA) 
and 0.12 U of T4(exo-) (Lucigen, Middleton, WI) was added to a final volume of 40 μL in 1× 
NEB2 buffer, and the mixture was incubated at 37 °C for 30 min. Finally, the mixture was 
subjected to purification by QIAquick PCR purification kit to remove proteins and excess 
nucleotides. 
 
OxoG Labeling 
 
A custom 40 nt oligonucleotide with a 5′ FAM (sequence: TCA CGA CTA GTG TTA ACA 
TGT GCA CCT GoCA GAA TGA GAA T, where Go is oxoG) was annealed to a complementary 
sequence by mixing both at an equimolar ratio, incubating in deionized water at 95 °C for 10 
min, and cooling to room temperature over 1 h. To excise oxoG, a 30 μL aliquot was prepared 
containing 100 pmol of duplex, 6.5 U hOGG1 (New England Biolabs), 40 U EndoIV, 3 μg BSA, 
and incubated in 1X NEB2 buffer at 37 °C for 1 h. Next, 1.5 nmol of biotinylated dGTP 
(PerkinElmer) and 0.12 U T4(exo-) were added to a final volume of 40 μL in 1X NEB2 buffer 
and the mixture was incubated at 37 °C for 30 min. Finally, the mixture was subjected to 
QIAquick PCR purification kit purification to remove proteins and excess nucleotides. 
 
T:G Mismatch Labeling 
 
A custom 40 nt oligonucleotide with a 5′ FAM (sequence: TCA CGA CTA GTG TTA ACA 
TGT CGA CCT TGA GAA TGA GAA T) was annealed to a complementary sequence (except 
with a guanine opposite the indicated thymine) by mixing both at an equimolar ratio, incubating 
in deionized water at 95 °C for 10 min, and cooling to room temperature over 1 h. To excise 
target thymine, a 30 μL aliquot was prepared containing 100 pmol of duplex, 7.5 mg of human 
TDG,(49) 40 fg of APE1 (D308A mutant(42)), 3 μg of BSA, and incubated in 1× HEMN.1 buffer 
(20 mM HEPES (pH 7.3), 100 mM NaCl, 2.5 mM MgCl2, 0.2 mM EDTA) at 37 °C for 1 h. The 
mixture was purified with a QIAquick PCR purification kit. Then, 40 U of EndoIV and 3 μg of 
BSA were added to a total volume of 30 μL in 1× NEB2 buffer and incubated at 37 °C for 30 
min. 1.5 nmol of biotinylated dCTP (PerkinElmer, Waltham, MA) and 0.12 U of T4(exo-) were 
added to a final volume of 40 μL in 1× NEB2 buffer, and the mixture was further incubated at 37 
°C for 30 min. Finally, the mixture was subjected to a second purification to remove proteins and 
excess nucleotides. 
 
1,N6-Ethenoadenine Labeling 
 
A custom 34 nt oligonucleotide with a 5′ FAM (sequence: CAG TTG AGG ATC CCC 
ATA AeTG CGG CTG TTT TCT G, where Ae is 1,N6-ethenoadenine) was annealed to a 
complementary sequence by mixing both at an equimolar ratio, incubating in deionized water at 
95 °C for 10 min, and cooling to room temperature over 1 h. To cap the 3′ ends of the DNA, a 
100 μL aliquot containing 385 pmol of duplex DNA, 30 nmol of ddATP, 500 U of terminal 
transferase, and 25 mmol of CoCl2 was incubated in 1× terminal transferase reaction buffer at 37 
°C for 1.5 h. The resulting material was purified with a QIAquick PCR purification kit to allow 
for buffer exchange. To excise target 1,N6-ethenoadenine, a 80 μL aliquot was prepared 
containing 100 pmol of duplex, 425 U of hAAG (New England Biolabs), 200 fg of APE1 D308A 
mutant, 8 μg of BSA, and 1× Thermopol buffer (New England Biolabs) and incubated at 37 °C 
for 1 h. The mixture was purified with a QIAquick PCR purification kit. Then, 40 U of EndoIV 
and 3 μg of BSA were added to a total volume of 30 μL in 1× NEB2 buffer and incubated at 37 
°C for 30 min. 1.5 nmol of biotinylated dATP (PerkinElmer, Waltham, MA) and 0.12 U of 
T4(exo-) were added to a final volume of 40 μL in 1× NEB2 buffer, and the mixture was further 
incubated at 37 °C for 30 min. Finally, the mixture was subjected to a second QIAquick 
purification to remove proteins and excess nucleotides. 
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